CD4 and atherosclerosis: Immature tolerogenic DCs, characterized by low expression levels of MHC class II molecule and costimulatory molecules, expand CD4+Foxp3+ Tregs and inhibit Teff responses, contributing to the maintenance of immune tolerance and regulation of atherosclerosis [92].